1114
G. KAUR ET AL.
[32] Ruiz, F.; Hazemann, I.; Mitschler, A.; Joachimiak, A.; Schneider, T.; Karplus, M.;
Podjarny, A. The Crystallographic Structure of the Aldose Reductase IDD552 Complex
Shows Direct Proton Donation from Tyrosine 48. Acta Cryst. 2004, D60, 1347–1354.
[33] Gong, B.; Hong, F.; Kohm, C.; Bonham, L.; Klein, P. Synthesis and SAR of 2-
Arylbenzoxazoles, Benzothiazoles And Benzimidazoles as Inhibitors of Lysophosphatidic
Acid Acyltransferase-Beta. Bioorg. Med. Chem. Lett. 2004, 14, 1455–1459. DOI: 10.1016/j.
[34] Klunk, W. E.; Engler, H.; Nordberg, A.; Wang, Y.; Blomqvist, G.; Holt, D. P.; Bergstro,
M.; Savitcheva, I.; Huang, G-f.; Estrada, S.; et al. Imaging Brain Amyloid in Alzheimer’s
disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55, 306–319. DOI: 10.1002/
ꢀ
[35] Auvity, S.; Tonietto, M.; Caille, F.; Bodini, B.; Bottlaender, M.; Tournier, N.; Kuhnast, B.;
Stankoff, B. Repurposing Radiotracers for Myelin Imaging: A Study Comparing
18F-Florbetaben, 18F-Florbetapir, 18F-Flutemetamol,11C-MeDAS, and 11C-PiB. Eur. J.
[36] Tao, Z.-F.; Hasvold, L.; Wang, L.; Wang, X.; Petros, A. M.; Park, C. H.; Boghaert, E. R.;
Catron, N. D.; Chen, J.; Colman, P. M.; et al. Discovery of a Potent and Selective BCL-
XL Inhibitor with in Vivo Activity. ACS Med. Chem. Lett. 2014, 5, 1088–1093. DOI: 10.
[37] IIScheetz, M. E.; Carlson, D. G.; Schinitsky, M. R. Frentizole,
a
Novel
Immunosuppressive, and Azathioprine: Their Comparative Effects on Host Resistance to
Pseudomonas aeruginosa, Candida albicans, Herpes Simplex Virus, and Influenza (Ann
[38] Hockly, E.; Tse, J.; Barker, A. L.; Moolman, D. L.; Beunard, J. L.; Revington, A. P.; Holt,
K.; Sunshine, S.; Moffitt, H.; Sathasivam, K.; et al. Evaluation of the Benzothiazole
Aggregation Inhibitors Riluzole and PGL-135 as Therapeutics for Huntington’s Disease.
[39] Bryson, H. M.; Fulton, B.; Benfield, P. Riluzole. A Review of Its Pharmacodynamic and
Pharmacokinetic Properties and Therapeutic Potential in Amyotrophic Lateral Sclerosis.
[40] Heusden, J. V.; Ginckel, R. V.; Bruwiere, H.; Moelans, P.; Janssen, B.; Floren, W.; der
Leede, B. J. V.; Dun, J. V.; Sanz, G.; Venet, M.; et al. Inhibition of all-TRANS-Retinoic
Acid Metabolism by R116010 Induces Antitumour Activity. Br. J. Cancer 2002, 86,
[41] Jordan, A. D.; Luo, C.; Reitz, A. B. Efficient Conversion of Substituted Aryl Thioureas to
2-Aminobenzothiazoles Using Benzyltrimethylammonium Tribromide. J. Org. Chem.
[42] Saini, S.; Dhiman, N.; Mittal, A.; Kumar, G. Synthesis and Antioxidant Activity of the 2-
Methyl Benzimidazole. J. Drug Deliv. Therap. 2016, 6, 100–102.
[43] Nannapaneni, D. T.; Gupta, A. V. S. S. S.; Reddy, M. I.; Sarva, R. C. Synthesis,
Characterization, and Biological Evaluation of Benzimidazole Derivatives as Potential
[44] Sawant, R.; Kawade, D. Synthesis and Biological Evaluation of Some Novel 2-Phenyl
Benzimidazole-1-Acetamide Derivatives as Potential Anthelmintic Agents. Acta Pharm.
[45] Coban, G.; Zencir, S.; Zupko, I.; Rethy, B.; Gunes, H. S.; Topcu, Z. Synthesis and
Biological Activity Evaluation of 1H-Benzimidazoles via Mammalian DNA
Topoisomerase I and Cytostaticity Assays. Eur. J. Med. Chem. 2009, 44, 2280–2285. DOI:
[46] Azam, M.; Khan, A. A.; Resayes, S. I. A.; Islam, M. S.; Saxena, A. K.; Dwivedi, S.;
Musarrat, J.; Kruszynska, A. T.; Kruszynski, R. Synthesis and Characterization of 2-
Substituted Benzimidazoles and Their Evaluation as Anticancer Agent. Spectrochim. Acta.